191 related articles for article (PubMed ID: 28400272)
1. Epigenetic processes in sporadic parathyroid neoplasms.
Silva-Figueroa AM; Perrier ND
Mol Cell Endocrinol; 2018 Jul; 469():54-59. PubMed ID: 28400272
[TBL] [Abstract][Full Text] [Related]
2. Alterations of DNA methylation in parathyroid tumors.
Guarnieri V; Muscarella LA; Verdelli C; Corbetta S
Mol Cell Endocrinol; 2018 Jul; 469():60-69. PubMed ID: 28501573
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic alterations in human parathyroid tumors.
Verdelli C; Forno I; Vaira V; Corbetta S
Endocrine; 2015 Jun; 49(2):324-32. PubMed ID: 25722013
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Alterations in Parathyroid Cancers.
Verdelli C; Corbetta S
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28157158
[TBL] [Abstract][Full Text] [Related]
5. Are Non-Coding RNAs Useful Biomarkers in Parathyroid Tumorigenesis?
Aurilia C; Donati S; Palmini G; Miglietta F; Falsetti I; Iantomasi T; Brandi ML
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638805
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification.
Svedlund J; Koskinen Edblom S; Marquez VE; Åkerström G; Björklund P; Westin G
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1307-15. PubMed ID: 22544915
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics of pituitary tumors: Pathogenetic and therapeutic implications.
Ezzat S; Cheng S; Asa SL
Mol Cell Endocrinol; 2018 Jul; 469():70-76. PubMed ID: 28711607
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Alterations of Heat Shock Proteins (HSPs) in Cancer.
Ban HS; Han TS; Hur K; Cho HS
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557887
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic dysregulation in adrenocortical carcinoma, a systematic review of the literature.
Jonker PKC; Meyer VM; Kruijff S
Mol Cell Endocrinol; 2018 Jul; 469():77-84. PubMed ID: 28830787
[TBL] [Abstract][Full Text] [Related]
11. Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype.
Haven CJ; Howell VM; Eilers PH; Dunne R; Takahashi M; van Puijenbroek M; Furge K; Kievit J; Tan MH; Fleuren GJ; Robinson BG; Delbridge LW; Philips J; Nelson AE; Krause U; Dralle H; Hoang-Vu C; Gimm O; Morreau H; Marsh DJ; Teh BT
Cancer Res; 2004 Oct; 64(20):7405-11. PubMed ID: 15492263
[TBL] [Abstract][Full Text] [Related]
12. Histone Modification on Parathyroid Tumors: A Review of Epigenetics.
Conti de Freitas LC; Castilho RM; Squarize CH
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628190
[TBL] [Abstract][Full Text] [Related]
13. [Genetic and epigenetic markers of gliomas].
Semenova EV; Filatov MV
Tsitologiia; 2013; 55(5):290-9. PubMed ID: 24592735
[TBL] [Abstract][Full Text] [Related]
14. Evolution of Epigenetic Mechanisms and Signatures.
Kalmykova A; Buzdin A
Cells; 2022 Dec; 12(1):. PubMed ID: 36611903
[TBL] [Abstract][Full Text] [Related]
15. Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours.
Juhlin CC; Kiss NB; Villablanca A; Haglund F; Nordenström J; Höög A; Larsson C
PLoS One; 2010 Mar; 5(3):e9472. PubMed ID: 20208994
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic biomarkers in prostate cancer: Current and future uses.
Chiam K; Ricciardelli C; Bianco-Miotto T
Cancer Lett; 2014 Jan; 342(2):248-56. PubMed ID: 22391123
[TBL] [Abstract][Full Text] [Related]
17. The effect of exposure to nanoparticles and nanomaterials on the mammalian epigenome.
Sierra MI; Valdés A; Fernández AF; Torrecillas R; Fraga MF
Int J Nanomedicine; 2016; 11():6297-6306. PubMed ID: 27932878
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic mechanisms of breast cancer: an update of the current knowledge.
Karsli-Ceppioglu S; Dagdemir A; Judes G; Ngollo M; Penault-Llorca F; Pajon A; Bignon YJ; Bernard-Gallon D
Epigenomics; 2014; 6(6):651-64. PubMed ID: 25531258
[TBL] [Abstract][Full Text] [Related]
19. Predicting resistance to endocrine therapy in breast cancer: It's time for epigenetic biomarkers (Review).
Fontes-Sousa M; Amorim M; Salta S; Palma De Sousa S; Henrique R; Jerónimo C
Oncol Rep; 2019 Mar; 41(3):1431-1438. PubMed ID: 30664168
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation in human melanoma: past and future.
Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
